Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis

被引:22
作者
Giddings, JC
Morris, RJ
Ralis, HM
Jennings, GM
Davies, DA
Woodcock, JP
机构
[1] Univ Wales Coll Med, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Wales Coll Med, Dept Med Phys & Bioengn, Cardiff CF14 4XN, S Glam, Wales
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2004年 / 26卷 / 04期
关键词
fibrinolysis; haemodynamics; plasminogen activators; thrombosis; veins;
D O I
10.1111/j.1365-2257.2004.00614.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intermittent pneumatic compression (IPC) is known to provide effective prophylaxis against post-surgical deep-vein thrombosis (DVT), and other procedures based on reducing venous stasis have been promoted recently to minimize the risk of thromboembolism after long-haul travel ('travellers thrombosis'). This study sought to measure the effects of IPC on systemic haemostasis, which are currently disputed. IPC was applied for 120 min on 21 male, non-smoking volunteers ranging in age from 19 to 47 years. IPC promoted a significant increase in global fibrinolytic potential. Levels of urokinase plasminogen activator activity (uPA) measured using an amidolytic assay were raised after IPC. However, enzyme-linked immunosorbent assays (ELISA) of uPA antigen, and the activities of tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) were not statistically different from those in control experiments. IPC led to highly significant falls in factor VIIa, associated with increased levels of tissue factor pathway inhibitor (TFPI). IPC enhances fibrinolysis and suppresses procoagulant activation. Measurements of specific fibrinolytic components do not reflect overall fibrinolytic activity and are highly dependent on the method of assay. The results provide important clues for detailed studies of the effects of haemodynamics on systemic haemostasis.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 30 条
[1]  
ALLENBY F, 1973, LANCET, V2, P1412
[2]   CIRCADIAN VARIATION OF FIBRINOLYTIC-ACTIVITY IN BLOOD [J].
ANDREOTTI, F ;
KLUFT, C .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) :336-351
[3]   Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) [J].
Bouma, BN ;
Marx, PF ;
Mosnier, LO ;
Meijers, JCM .
THROMBOSIS RESEARCH, 2001, 101 (05) :329-354
[4]   Intermittent pneumatic compression devices - Physiological mechanisms of action [J].
Chen, AH ;
Frangos, SG ;
Kilaru, S ;
Sumpio, BE .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2001, 21 (05) :383-392
[5]   Inhibition of tissue factor pathway during intermittent pneumatic compression - A possible mechanism for antithrombotic effect [J].
Chouhan, VD ;
Comerota, AJ ;
Sun, L ;
Hada, R ;
Gaughan, JP ;
Rao, AK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) :2812-2817
[6]   Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity [J].
Christen, Y ;
Wutschert, R ;
Weimer, D ;
deMoerloose, P ;
Kruithof, EKO ;
Bounameaux, H .
BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (03) :185-190
[7]   The fibrinolytic effects of intermittent pneumatic compression - Mechanism of enhanced fibrinolysis [J].
Comerota, AJ ;
Chouhan, V ;
Harada, RN ;
Sun, L ;
Hosking, J ;
Veermansunemi, R ;
Comerota, AJ ;
Schlappy, D ;
Rao, AK .
ANNALS OF SURGERY, 1997, 226 (03) :306-313
[8]  
Giangrande PLF, 2001, INT J CLIN PRACT, V55, P690
[9]   A NOVEL PRINCIPLE FOR ASSESSMENT OF STIMULATED FIBRINOLYSIS [J].
HAALAND, AK ;
SKJONSBERG, OH ;
VAERET, A ;
RUYTER, R ;
GODAL, HC .
THROMBOSIS RESEARCH, 1991, 62 (06) :725-735
[10]   PREVENTION OF DEEP VEIN-THROMBOSIS BY INTERMITTENT PNEUMATIC COMPRESSION OF CALF [J].
HILLS, NH ;
BOARDMAN, L ;
CALNAN, JS ;
PFLUG, JJ ;
JEYASINGH, K .
BMJ-BRITISH MEDICAL JOURNAL, 1972, 1 (5793) :131-+